NCT02926703View on ClinicalTrials.gov

Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure

CompletedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
SeizureSyncope
Interventions
OTHER

Serum lactate and CK concentrations in blood samples

Serum lactate and CK concentrations in blood samples were measured routinely at admission

Trial Locations (1)

52074

Department of Neurology/Emergency department, University Hospital RWTH Aachen, Aachen

All Listed Sponsors
lead

RWTH Aachen University

OTHER

NCT02926703 - Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure | Biotech Hunter | Biotech Hunter